Clinical Trial Update: QA108 Phase III Study in Subjects With Intermediate AMD [Phase 3]

View source ↗

Summary

QA108's Phase III trial for intermediate age-related macular degeneration is currently recruiting, with no results reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• QA108

Snippet

Sponsor: Smilebiotek Zhuhai Limited | Conditions: Intermediate Age-Related Macular Degeneration | Phase 3 | Status: RECRUITING